The uninsured rates may skyrocket when Medicaid work requirements go into effect and if the Affordable Care Act (ACA) ...

A retrospective analysis of anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR T) therapy outcomes ...

GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and ...

Soluble TAM receptors (sTAMs) could serve as biomarkers for RA, indicating disease activity, severity, and prognosis, though standardized detection methods are needed. TAM receptors could emerge as ...

A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...

Panelists discuss how nonstatin agents are chosen and when combination therapy should be introduced for high-risk patients.

Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve. Stay ahead ...

In an interview with The American Journal of Managed Care® ( AJMC®), Mike Camacho, president of SLTCM, identifies 5 key strategies that ACOs can utilize to improve care and achieve meaningful savings, ...

Panelists discuss how overcoming logistical and perceptual barriers will drive wider adoption of SC therapies in NSCLC.

The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...

“The monoclonal antibodies rituximab, ocrelizumab, ofatumumab (Kesimpta), and ublituximab (Briumvi) provide outstanding ...

Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...